Forecast & Rating4 analysts currently cover Cellectar Bioscience, of which 4 give a positive rating. The average price target is $11.50, about 344.0% upside from the current price of $2.59. Coverage is limited, so the data is for reference only. Data as of Aug 18, 2026; this does not constitute investment advice.
Aug 18, 2026Price forecast
$11.50344.02%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met0.0%
Stock price$2.59
Avg. target$47.0
High target$76
Low target$18
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.